New Article Spotlight: A Call for Standardized Genetic Testing in Breast Cancer Care
A new article in Healthy Debate—“It’s time to act: Canada needs standardized genetic testing for breast cancer care”—highlights a critical gap in our healthcare system.
Access to hereditary cancer genetic testing in Canada remains inconsistent, leaving many patients without timely information to guide treatment, reduce future cancer risk, and inform family members.
For the 5–10% of breast cancers linked to inherited risk, genetic testing can enable personalized care and preventive strategies. Yet outdated guidelines, long wait times, and regional disparities continue to limit access.
Key recommendations include:
Expanding testing eligibility (especially for those diagnosed at 65 or under)
Using standardized multigene panel testing beyond BRCA1/2
Integrating testing earlier in care
Ensuring access to clear information and timely counselling
Together, these changes aim to create more equitable, patient-centered care across Canada.